Total
0
Shares
Mach7 Technologies (ASX:M7T) - CEO, Mike Lampron - The Market Herald
CEO, Mike Lampron
Source: Mach7 Technologies
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Mach7 Technologies (M7T) has secured a $7.9 million contract through its wholly-owned subsidiary with U.S. nonprofit Adventist Health System
  • Mach7 is set to roll out its full suite of picture archive communication system across 22 hospitals in the U.S., with the first round of orders expected this quarter
  • The $7.9 million arrangement includes migration services and five years of support and maintenance
  • Mach7 Chief Executive Officer Mike Lampron said he is delighted with the new collaborative partnership
  • Mach7 shares are trading 9.40 per cent higher at $1.46 each

Mach7 Technologies (M7T) has secured a $7.9 million contract through its wholly-owned subsidiary with U.S. nonprofit, Adventist Health System.

The contract amendment is for its license of the Mach7 PACS (Picture Archive Communication System), an integrated enterprise imaging solution designed to streamline hospital workflows.

The initial contract with Adventist in April 2020 included the provision of its eUnity Diagnostic Viewer and Mach7 Universal Worklist to one of the hospitals in the Adventist Health network.

Now, under the new contract, Mach7 will supply its full suite of PACS services across 22 hospitals in California, Hawaii and Oregon as part of the Adventist PACS replacement program.

The $7.9 million arrangement includes migration services and five years of support and maintenance.

According to the company, the software deployment will be implemented in stages as and when software licenses are ordered by individual hospitals in the Adventist Health group.

Mac7 expects the first round of orders for the quarter to represent roughly 7 per cent of the total contract value, as part of its longer-term goal to roll out Mach7 PACS across the majority of Adventist Health hospitals by the end of 2021.

Mach7 Chief Executive Officer Mike Lampron said he is delighted with the partnership.

"The collaborative partnership we have established with Adventist Health has allowed us to help them expand their enterprise imaging growth strategy," he explained.

"I am confident Mach7's full Enterprise PACS solution will provide a flexible
and scalable foundation that meets the needs of radiologists across their health
network," he added.

Mach7 shares are trading 9.40 per cent higher at $1.46 each at 12:01 pm AEDT.

M7T by the numbers
More From The Market Herald
Pacific Smiles (ASX:PSQ) raises $15M for dental centre rollout

" Pacific Smiles (ASX:PSQ) raises $15M for dental centre rollout

Dental centre operator Pacific Smiles (PSQ) has successfully completed its $15 million placement.
MGC Pharmaceuticals (ASX:MXC) - Co Founder and Managing Director, Roby Zomer - The Market Herald

" MGC Pharmaceuticals (ASX:MXC) receives boosted ArtemiC order from SPC

MGC Pharmaceuticals (MXC) has received a significantly increased order from Swiss PharmaCan (SPC) for its ArtemiC Rescue product line.
Orthocell (ASX:OCC) - Managing Director, Paul Anderson - The Market Herald

" Orthocell (ASX:OCC) granted inclusion on Australian Prostheses List

Regenerative medicine company Orthocell (OCC) has been granted inclusion on the Australian Prostheses List.
Palla Pharma (ASX:PAL) raises $12.2M to improve working capital

" Palla Pharma (ASX:PAL) raises $12.2M to improve working capital

Pharmaceutical company Palla Pharma (PAL) has raised roughly $12.24 million via a placement and institutional entitlement offer.